Zobrazeno 1 - 10
of 21
pro vyhledávání: '"the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee"'
Autor:
Jacqueline G. Gerhart, Kevin M. Watt, Andrea Edginton, Kelly C. Wade, Sara N. Salerno, Daniel K. Benjamin Jr, P. Brian Smith, Christoph P. Hornik, Michael Cohen‐Wolkowiez, Shahnaz Duara, Ashley Ross, Karen Shattuck, Dan L. Stewart, Natalie Neu, Daniel Gonzalez, the Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 7, Pp 500-510 (2019)
Fluconazole is used to treat hematogenous Candida meningoencephalitis in preterm and term infants. To characterize plasma and central nervous system exposure, an adult fluconazole physiologically‐based pharmacokinetic (PBPK) model was scaled to inf
Externí odkaz:
https://doaj.org/article/7d2b1a51f05e4740a751175400d3d625
Autor:
Elizabeth J. Thompson, Angela Jeong, Victória E. Helfer, Valentina Shakhnovich, Andrea Edginton, Stephen J. Balevic, Laura P. James, David N. Collier, Ravinder Anand, Daniel Gonzalez, the Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 8, Pp 1394-1408 (2024)
Abstract Pantoprazole is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease, a condition that disproportionately affects children with obesity. Appropriately dosing pantoprazole in children with obesity requires un
Externí odkaz:
https://doaj.org/article/4ca30823adfe493396f3130d6019af5f
Autor:
Kanecia O. Zimmerman, Brian Perry, Emily Hanlen‐Rosado, Adora Nsonwu, Morgan D. Lane, Daniel K. Benjamin, Mara Becker, Amy Corneli, Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee
Publikováno v:
Health Expectations, Vol 25, Iss 3, Pp 1029-1037 (2022)
Abstract Introduction Better transparency of research results and participant engagement may help address poor participant accrual in paediatric clinical research. We conducted formative research to assess the acceptability of lay summaries and thank
Externí odkaz:
https://doaj.org/article/c29ca3de738d4b7eb790aca072382a4a
Autor:
Carreño, Fernando O., Gerhart, Jacqueline G., Helfer, Victória E., Sinha, Jaydeep, Kumar, Karan R., Kirkpatrick, Carl, Hornik, Christoph P., Gonzalez, Daniel, the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee, Benjamin Jr., Daniel K., Zimmerman, Kanecia, Kennel, Phyllis, Alderman, Cheryl, Sund, Zoe, Opel, Kylie, Beci, Rose, Hornik, Chi Dang, Kearns, Gregory L., Laughon, Matthew, Paul, Ian M.
Publikováno v:
Clinical Pharmacokinetics; Jul2024, Vol. 63 Issue 7, p999-1014, 16p
Autor:
Maglalang, Patricia D., Sinha, Jaydeep, Zimmerman, Kanecia, McCann, Sean, Edginton, Andrea, Hornik, Christoph P., Hornik, Chi D., Muller, William J., Al-Uzri, Amira, Meyer, Marisa, Chen, Jia-Yuh, Anand, Ravinder, Perrin, Eliana M., Gonzalez, Daniel, the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee, Benjamin Jr, Daniel K., Kennel, Phyllis, Alderman, Cheryl, Sund, Zoe, Opel, Kylie
Publikováno v:
Clinical Pharmacokinetics; Jun2024, Vol. 63 Issue 6, p885-899, 15p
Autor:
Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee, Ericson, Jessica E., Kaufman, David A., Kicklighter, Stephen D., Bhatia, Jatinder, Testoni, Daniela, Gao, Jamie, Smith, P. Brian, Prather, Kristi O., Benjamin, Daniel K.
Publikováno v:
Clinical Infectious Diseases, 2016 Sep 01. 63(5), 604-610.
Externí odkaz:
https://www.jstor.org/stable/26371959
Autor:
Ge, Shufan, Mendley, Susan R, Gerhart, Jacqueline G, Melloni, Chiara, Hornik, Christoph P, Sullivan, Janice E, Atz, Andrew, Delmore, Paula, Tremoulet, Adriana, Harper, Barrie, Payne, Elizabeth, Lin, Susan, Erinjeri, Jinson, Cohen-Wolkowiez, Michael, Gonzalez, Daniel, Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee
Publikováno v:
Clinical and translational science, vol 13, iss 6
Metoclopramide is commonly used for gastroesophageal reflux. The aims of the present study were to develop a pediatric population pharmacokinetic (PopPK) model, which was applied to simulate the metoclopramide exposure following dosing used in clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::4157b67e8d76bf557c830f7a69d8df97
https://escholarship.org/uc/item/9c95z16h
https://escholarship.org/uc/item/9c95z16h
Autor:
Gerhart, Jacqueline G., Carreño, Fernando O., Edginton, Andrea N., Sinha, Jaydeep, Perrin, Eliana M., Kumar, Karan R., Rikhi, Aruna, Hornik, Christoph P., Harris, Vincent, Ganguly, Samit, Cohen-Wolkowiez, Michael, Gonzalez, Daniel, the Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee, Benjamin Jr., Daniel K., Hornik, Christoph, Zimmerman, Kanecia, Kennel, Phyllis, Beci, Rose, Hornik, Chi Dang, Kearns, Gregory L.
Publikováno v:
Clinical Pharmacokinetics; Feb2022, Vol. 61 Issue 2, p307-320, 14p
Autor:
Ganguly, Samit, Edginton, Andrea N., Gerhart, Jacqueline G., Cohen-Wolkowiez, Michael, Greenberg, Rachel G., Gonzalez, Daniel, the Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee, Benjamin Jr, Daniel K., Hornik, Christoph, Zimmerman, Kanecia, Kennel, Phyllis, Beci, Rose, Hornik, Chi Dang, Kearns, Gregory L., Laughon, Matthew, Paul, Ian M., Sullivan, Janice, Wade, Kelly, Delmore, Paula, Taylor-Zapata, Perdita
Publikováno v:
Clinical Pharmacokinetics; Dec2021, Vol. 60 Issue 12, p1591-1604, 14p
Autor:
Maharaj, Anil R., Wu, Huali, Zimmerman, Kanecia O., Muller, William J., Sullivan, Janice E., Sherwin, Catherine M. T., Autmizguine, Julie, Rathore, Mobeen H., Hornik, Chi D., Al-Uzri, Amira, Payne, Elizabeth H., Benjamin Jr, Daniel K., Hornik, Christoph P., The Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee, Hornik, Christoph, Zimmerman, Kanecia, Kennel, Phyllis, Beci, Rose, Hornik, Chi Dang, Kearns, Gregory L.
Publikováno v:
Pediatric Drugs; Sep2021, Vol. 23 Issue 5, p499-513, 15p